Prospective Validation of the LCrossed D sign©mann Index in Children: A Report from the Multicentre Image Kids Study

Gili Focht, Ruth Cytter Kuint, Mary Louise C. Greer, Li Tal Pratt, Denise A. Castro, Peter C. Church, Víctor Manuel Navas-López, Robert N. Baldassano, Joachim Høg Mortensen, Florian Rieder, Baruch Yerushalmi, Anat Ilivitzki, Osnat Konen, Anne M. Griffiths, Dan Turner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Background:

Original languageAmerican English
Pages (from-to)943-949
Number of pages7
JournalJournal of Crohn's and Colitis
Volume17
Issue number6
DOIs
StatePublished - 1 Jun 2023

Bibliographical note

Funding Information:
GF—received in the past 3 years consultancy fees from Abbvie and Lilly. RCK—received in the past 3 years consultancy fees from Alnylam. MLG—received in the past 3 years an AbbVie investigator-initiated research grant and honoraria, Samsung honoraria. LP, DAC, RNB, BY, AI, OK—None. PC—received in the past 3 years speaker fees, consultancy fees or grants from Abbvie, Amgen, Janssen, Takeda and Viatris. VMNL—received in past 3 years speaker fees, consultancy fees or grants from Abbvie, Rb, Nestle Health Science, Ordesa, Lactalis and Adacyte Therapeutics. JHM—None. FR—received in past 3 years consultancy fees from Adnovate, Agomab, Allergan, AbbVie, Arena, Boehringer-Ingelheim, Celgene/BMS, CDISC, Celsius, Cowen, Ferring, Galapagos, Galmed, Genentech, Gilead, Gossamer, Guidepoint, Helmsley, Horizon Therapeutics, Image Analysis Limited, Index Pharma, Jannsen, Koutif, Mestag, Metacrine, Mopac, Morphic, Organovo, Origo, Pfizer, Pliant, Prometheus Biosciences, Receptos, RedX, Roche, Samsung, Surmodics, Surrozen, Takeda, Techlab, Theravance, Thetis, UCB, Ysios and 89Bio. AMG—received in the past 3 years consultancy fees from Abbvie, Amgen, Bristol Myers Squibb, Lilly, Janssen, Merck, Pfizer, Takeda; speaker fees from Abbvie, Janssen; investigator-initiated research grant from Abbvie. DT—received in the past 3 years consultancy fees, research grant, royalties or honorarium from Janssen, Pfizer, Hospital for Sick Children, Ferring, Abbvie, Takeda, Atlantic Health, Shire, Celgene, Lilly, Roche, ThermoFisher, BMS. Acknowledgments

Funding Information:
The ImageKids study was supported by an educational grant from AbbVie (grant number IMM-11-0077), which was not involved in any part of the study including protocol preparation, data acquisition, analyses or manuscript preparation.

Publisher Copyright:
© 2023 Oxford University Press. All rights reserved.

Keywords

  • Crohn's disease
  • Lemann score
  • MRE
  • Paediatrics

Fingerprint

Dive into the research topics of 'Prospective Validation of the LCrossed D sign©mann Index in Children: A Report from the Multicentre Image Kids Study'. Together they form a unique fingerprint.

Cite this